Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
Sales | 127 | 105 | 102 | 104 | 144 |
Gross Profit | 127 | 105 | 102 | 104 | 144 |
Operating Expenses | 2,423 | 2,045 | 1,745 | 1,789 | 4,084 |
Operating Income | -2,296 | -1,940 | -1,643 | -1,685 | -3,940 |
Interest Expense | 152 | 143 | 149 | 144 | 133 |
Other Income | -10,271 | 3,873 | 2,881 | -7,143 | 2 |
Pre-tax Income | -12,719 | 1,790 | 1,089 | -8,972 | -4,071 |
Net Income Continuous | -12,719 | 1,790 | 1,089 | -8,972 | -4,071 |
Net Income | $-12,719 | $1,790 | $1,089 | $-8,972 | $-4,071 |
EPS Basic Total Ops | -1,037.50 | 112.50 | 50.00 | -975.00 | -462.50 |
EPS Basic Continuous Ops | -1,007.91 | 144.73 | 92.18 | -926.25 | -416.94 |
EPS Diluted Total Ops | -1,037.50 | 87.50 | 50.00 | -975.00 | -462.50 |
EPS Diluted Continuous Ops | -1,007.91 | 80.09 | 76.66 | -926.25 | -416.94 |
EBITDA(a) | $-2,237 | $-1,881 | $-1,582 | $-1,623 | $-3,875 |